Vertex Pharmaceuticals Incorporated (VRTX): Price and Financial Metrics

VRTX POWR Grades

• VRTX scores best on the Value dimension, with a Value rank ahead of 93.6% of US stocks.
• VRTX's strongest trending metric is Momentum; it's been moving down over the last 52 weeks.
• VRTX ranks lowest in Momentum; there it ranks in the 9th percentile.

VRTX Stock Summary

• VRTX has a market capitalization of $47,752,984,484 -- more than approximately 94.15% of US stocks.
• VRTX's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 295.13 -- higher than 90.15% of US-listed equities with positive expected earnings growth.
• Of note is the ratio of Vertex Pharmaceuticals Inc's sales and general administrative expense to its total operating expenses; only 9.76% of US stocks have a lower such ratio.
• Stocks that are quantitatively similar to VRTX, based on their financial statements, market capitalization, and price volatility, are REGN, NTLA, VIR, NRIX, and SGMO.
• Visit VRTX's SEC page to see the company's official filings. To visit the company's web site, go to www.vrtx.com.

VRTX Valuation Summary

• VRTX's price/sales ratio is 7.8; this is 105.26% higher than that of the median Healthcare stock.
• Over the past 243 months, VRTX's price/earnings ratio has gone up 70.8.
• Over the past 243 months, VRTX's price/sales ratio has gone down 26.7.

Below are key valuation metrics over time for VRTX.

VRTX Growth Metrics

• Its 4 year revenue growth rate is now at 273.05%.
• Its 5 year price growth rate is now at 198.58%.
• Its 3 year cash and equivalents growth rate is now at 311.88%.

VRTX's revenue has moved up $1,864,273,000 over the prior 15 months.

The table below shows VRTX's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-06-30	6,683.766	2,120.568	1,991.686
2021-03-31	6,414.881	3,358.862	2,762.032
2020-12-31	6,205.683	3,253.505	2,711.647
2020-09-30	5,991.128	3,207.981	2,690.691
2020-06-30	5,402.685	2,635.022	2,080.775
2020-03-31	4,819.493	2,060.244	1,510.932

VRTX's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• VRTX has a Quality Grade of B, ranking ahead of 86.59% of graded US stocks.
• VRTX's asset turnover comes in at 0.564 -- ranking 68th of 680 Pharmaceutical Products stocks.
• ORGO, MDWD, and CCXI are the stocks whose asset turnover ratios are most correlated with VRTX.

The table below shows VRTX's key quality metrics over time.